These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32683296)

  • 21. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach.
    Abdelmageed MI; Abdelmoneim AH; Mustafa MI; Elfadol NM; Murshed NS; Shantier SW; Makhawi AM
    Biomed Res Int; 2020; 2020():2683286. PubMed ID: 32461973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
    Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
    PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A candidate multi-epitope vaccine against SARS-CoV-2.
    Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
    Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
    Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z
    Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
    Lon JR; Bai Y; Zhong B; Cai F; Du H
    Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2.
    Rakib A; Sami SA; Islam MA; Ahmed S; Faiz FB; Khanam BH; Marma KKS; Rahman M; Uddin MMN; Nainu F; Emran TB; Simal-Gandara J
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33147821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unbiased Screens Show CD8
    Ferretti AP; Kula T; Wang Y; Nguyen DMV; Weinheimer A; Dunlap GS; Xu Q; Nabilsi N; Perullo CR; Cristofaro AW; Whitton HJ; Virbasius A; Olivier KJ; Buckner LR; Alistar AT; Whitman ED; Bertino SA; Chattopadhyay S; MacBeath G
    Immunity; 2020 Nov; 53(5):1095-1107.e3. PubMed ID: 33128877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
    Banerjee A; Santra D; Maiti S
    J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
    Galili U
    Vaccine; 2020 Sep; 38(42):6487-6499. PubMed ID: 32907757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2.
    Panda PK; Arul MN; Patel P; Verma SK; Luo W; Rubahn HG; Mishra YK; Suar M; Ahuja R
    Sci Adv; 2020 Jul; 6(28):eabb8097. PubMed ID: 32691011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
    PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Samrat SK; Tharappel AM; Li Z; Li H
    Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
    Ong E; Wong MU; Huffman A; He Y
    Front Immunol; 2020; 11():1581. PubMed ID: 32719684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.